Skip to main content
editorial
. 2017 Jul 1;3(3):117–123. doi: 10.1016/S2055-6640(20)30329-0

Table 1.

Table showing the regional breakdown of epidemic size, new infections, number cured and HCV-related deaths. Using the data, the net change in epidemic size between 2016 and 2017 has been calculated. Estimated data is used for countries missing from the analysis. A global estimate for the burden of HCV is included as the sum of all regions, including missing countries

Region HCV Epidemic 2016 New HCV infections Number cured HCV-related deaths HCV Epidemic 2017 Net change
Asia and Pacific 29,564,900 574,330 456,552 179,810 29,502,868 −62,032
Central and Eastern Europe 6,507,700 322,800 26,110 15,505 6,788,885 +281,185
Latin and South America 3,477,400 27,537 47,859 21,496 3,435,582 −40,548
North Africa and Middle East 7,399,470 156,660 542,724 51,944 6,961,462 −438,008
North America 2,955,600 31,870 216,731 20,829 2,749,910 −205,690
Sub-Saharan Africa 5,069,000 130,800 3,805 21,540 5,174,455 +105,455
Western Europe 2,364,430 35,440 105,821 14,951 2,279,098 −85,332
91 country subtotal 57,338,500 1,279,437 1,399,602 326,075 56,892,260 −446,240
Missing countries 12,216,308 318,375 113,157 57,923 12,363,603 +147,295
Global estimate 69,554,808 1,597,812 1,512,759 383,998 69,255,863 298,945